Search Results 1981-1990 of 20076 for Receptor

  1. Effect of Tirzepatide on Physical Function in Postmenopausal Women With Obesity - Mayo Clinic

    Therefore, our overarching goal is to determine the effect of weight loss induced by the new generation of GLP-1 receptor agonists on physical function ...

  2. A Study of the Effects of Decreasing the Lasix Dose on the Cardiorenal System - Mayo Clinic

    ... receptor type 1 blocker over the past 3 months; No episode of decompensated CHF over the past 6 months. Calculated creatinine clearance of equal or less than ...

  3. Shaping the Future of Breast Cancer Care at Mayo Clinic: One Trainee at a Time - News Archive

    Her studies focus on a form of breast cancer classified as estrogen receptor positive (ER+), which is usually treated effectively by drugs that block estrogen ...

  4. Tricyclic antidepressants and tetracyclic antidepressants - Mayo Clinic

    Tricyclic antidepressants can have more side effects than other antidepressants. But for some people, they may ease depression when other medicines fail.

  5. PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies - Mayo Clinic

    Prior therapy with CD123- or IL-3R-directed immunotherapies, including monospecific and bsAbs, immunoconjugates, or chimeric antigen receptor-modified T-cell ...

  6. Publications - Reade A. Quinton, M.D. - Mayo Clinic

    Epub 2020 Nov 16. View PubMed; Shahi M, Mamber Czeresnia R, Cheek EH, Quinton RA, Chakraborty R, Enninga EAL. Expression of Immune Checkpoint Receptors in ...

  7. A Study to Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs to Treat Patients with Mantle Cell Lymphoma - Mayo Clinic

    receptor modified T-cell (CAR-T) therapy within 60 days of randomization - Clinically significant cardiovascular disease - Prolonged QT interval corrected ...

  8. Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension - Mayo Clinic

    ... receptor agonists (eg, selexipag) are permitted if stopped 24 hours prior to the start of study drug administration. - Any new ventricular or ...

  9. A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) - Mayo Clinic

    ... receptor alpha (PDGFRA) mutation, who has progressed on or was intolerant to at least 1 approved tyrosine kinase inhibitor (TKI) regimen in the advanced ...

  10. Publications - Dan P. Larson, M.D. - Mayo Clinic

    Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression. Nat Biomed Eng. 2024 Apr; 8 (4):443-460 Epub 2024 Apr 01. View ...